HTG Molecular Diagnostics Past Earnings Performance
Past criteria checks 0/6
HTG Molecular Diagnostics's earnings have been declining at an average annual rate of -7.2%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been declining at an average rate of 28.2% per year.
Key information
-7.2%
Earnings growth rate
48.0%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | -28.2% |
| Return on equity | -4,246.9% |
| Net Margin | -324.3% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
HTG Molecular Q2 GAAP loss per share widens, revenue down
Aug 11HTG Molecular Diagnostics amends senior loan facility
Jul 18Is HTG Molecular Diagnostics (NASDAQ:HTGM) Using Debt In A Risky Way?
Dec 10
Is HTG Molecular Diagnostics (NASDAQ:HTGM) Weighed On By Its Debt Load?
Aug 27HTG Molecular completes product design lock for planned transcriptome panel
Jun 14These Analysts Think HTG Molecular Diagnostics, Inc.'s (NASDAQ:HTGM) Sales Are Under Threat
Mar 26What Type Of Returns Would HTG Molecular Diagnostics'(NASDAQ:HTGM) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 20
HTG shares surge after upbeat 2020 revenue forecast
Jan 05HTG Molecular Diagnostics announced 1:15 reverse stock split
Nov 23HTG Molecular Diagnostics (HTGM) Investor Presentation - Slideshow
Nov 18Revenue & Expenses BreakdownBeta
How HTG Molecular Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 6 | -20 | 14 | 0 |
| 31 Dec 22 | 6 | -22 | 16 | 0 |
| 30 Sep 22 | 7 | -22 | 18 | 0 |
| 30 Jun 22 | 8 | -22 | 19 | 0 |
| 31 Mar 22 | 9 | -19 | 18 | 0 |
| 31 Dec 21 | 9 | -17 | 17 | 0 |
| 30 Sep 21 | 9 | -16 | 17 | 0 |
| 30 Jun 21 | 8 | -17 | 17 | 0 |
| 31 Mar 21 | 8 | -20 | 17 | 0 |
| 31 Dec 20 | 9 | -21 | 18 | 0 |
| 30 Sep 20 | 11 | -21 | 19 | 0 |
| 30 Jun 20 | 14 | -20 | 18 | 0 |
| 31 Mar 20 | 18 | -19 | 19 | 0 |
| 31 Dec 19 | 19 | -19 | 19 | 0 |
| 30 Sep 19 | 22 | -17 | 19 | 0 |
| 30 Jun 19 | 21 | -17 | 19 | 0 |
| 31 Mar 19 | 21 | -16 | 19 | 0 |
| 31 Dec 18 | 22 | -16 | 20 | 0 |
| 30 Sep 18 | 22 | -16 | 20 | 0 |
| 30 Jun 18 | 21 | -17 | 19 | 0 |
| 31 Mar 18 | 18 | -19 | 19 | 0 |
| 31 Dec 17 | 15 | -19 | 18 | 0 |
| 30 Sep 17 | 8 | -23 | 17 | 0 |
| 30 Jun 17 | 6 | -24 | 17 | 0 |
| 31 Mar 17 | 6 | -25 | 17 | 0 |
| 31 Dec 16 | 5 | -26 | 17 | 0 |
| 30 Sep 16 | 5 | -26 | 17 | 0 |
| 30 Jun 16 | 5 | -25 | 17 | 0 |
| 31 Mar 16 | 4 | -25 | 16 | 0 |
| 31 Dec 15 | 4 | -23 | 15 | 0 |
| 30 Sep 15 | 4 | -22 | 14 | 0 |
| 30 Jun 15 | 4 | -21 | 13 | 0 |
| 31 Mar 15 | 4 | -19 | 11 | 0 |
| 31 Dec 14 | 3 | -18 | 10 | 0 |
| 30 Sep 14 | 3 | -16 | 9 | 0 |
| 30 Jun 14 | 2 | -15 | 8 | 0 |
| 31 Mar 14 | 3 | -14 | 8 | 0 |
| 31 Dec 13 | 2 | -14 | 8 | 0 |
Quality Earnings: HTGM.Q is currently unprofitable.
Growing Profit Margin: HTGM.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if HTGM.Q's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare HTGM.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HTGM.Q is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).
Return on Equity
High ROE: HTGM.Q has a negative Return on Equity (-4246.92%), as it is currently unprofitable.